Evrysdi (Risdiplam POWDER) 0.75mg/1ml

Evrysdi (risdiplam) is a prescription oral solution used for spinal muscular atrophy in adults and children. This powder form must be reconstituted before use. Find risdiplam uses, dosing, and side effects here.

Strength

0.75mg/1ml

Pack Size

Manufacturer / TM Owner

Roche

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Evrysdi is prescribed to treat spinal muscular atrophy, a genetic condition affecting muscle control. It works by increasing survival motor neuron protein levels in the body. People often ask what is risdiplam used for and how it may help manage SMA symptoms. This medication is suitable for pediatric and adult patients as directed by a healthcare provider.

Side Effects

Evrysdi helps maintain motor function and may slow disease progression in SMA. Users may notice improved muscle strength or reduced fatigue over time. Some people report better daily activity performance after consistent use. Individual responses vary based on condition severity and medical guidance.

Precautions & Warnings

Store unopened risdiplam powder at room temperature away from moisture and heat. Keep the reconstituted solution refrigerated and use within the specified timeframe. Always follow handling instructions to maintain potency. Discard any unused portion after the recommended period to ensure safety.

Avoid Interactions

Certain medications may affect how risdiplam works, including strong CYP3A inhibitors or inducers. Avoid grapefruit products unless approved by a doctor. Some supplements and herbal remedies could also interact. Always inform your healthcare provider about all drugs and supplements you take.

Frequently Asked Questions

Mix the powder with water as directed in the patient information leaflet before first use.

Yes, risdiplam can be taken with or without food, but follow your doctor’s specific instructions.

Take the missed dose as soon as you remember, unless it’s nearly time for the next dose; skip it if uncertain.

Evrysdi is approved for pediatric and adult use under medical supervision for SMA treatment.

Response varies; some patients notice changes within weeks, while others may take longer.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.